Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies

ME Bahar, HJ Kim, DR Kim - Signal transduction and targeted therapy, 2023 - nature.com
Metastatic dissemination of solid tumors, a leading cause of cancer-related mortality,
underscores the urgent need for enhanced insights into the molecular and cellular …

[HTML][HTML] Targeting BRAF mutations in non-small cell lung cancer

CG O'Leary, V Andelkovic, R Ladwa… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
The management of non-small cell lung cancer (NSCLC) has changed significantly with the
discovery of specific drug targets. These drugs have helped transform patient care and …

Integrated proteogenomic characterization across major histological types of pediatric brain cancer

F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury… - Cell, 2020 - cell.com
We report a comprehensive proteogenomics analysis, including whole-genome sequencing,
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …

Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities

D Cheasley, A Nigam, M Zethoven… - The Journal of …, 2021 - Wiley Online Library
Low‐grade serous ovarian carcinoma (LGSOC) is associated with a poor response to
existing chemotherapy, highlighting the need to perform comprehensive genomic analysis …

Inhibition of RAF dimers: it takes two to tango

FA Cook, SJ Cook - Biochemical Society Transactions, 2021 - portlandpress.com
The RAS-regulated RAF–MEK1/2–ERK1/2 pathway promotes cell proliferation and survival
and RAS and BRAF proteins are commonly mutated in cancer. This has fuelled the …

[HTML][HTML] Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era

N Manoharan, KX Liu, S Mueller, DA Haas-Kogan… - Neoplasia, 2023 - Elsevier
Abstract pLGGs are a group of tumors for which the era of molecular diagnostics has truly
shifted treatment paradigms and patient care. The discovery that this group of tumors is …

[HTML][HTML] Personality changes and staring spells in a 12-year-old child: a case report incorporating ChatGPT, a natural language processing tool driven by Artificial …

V Puthenpura, S Nadkarni, M DiLuna, K Hieftje… - Cureus, 2023 - ncbi.nlm.nih.gov
Low grade gliomas (LGGs) are the most common type of brain tumors diagnosed in children.
The presentation of intracranial tumors in pediatric patients is varied and diverse. The early …

Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity

A Arnold, M Yuan, A Price, L Harris… - Neuro …, 2020 - academic.oup.com
Background Pediatric low-grade glioma (pLGG) is the most common childhood brain tumor.
Many patients with unresectable or recurrent/refractory tumors have significant lifelong …

BRAF Alteration in Central and Peripheral Nervous System Tumors

K Srinivasa, KA Cross, S Dahiya - Frontiers in Oncology, 2020 - frontiersin.org
BRAF (alternately referred to as v-raf murine sarcoma viral oncogene homolog B1) is a proto-
oncogene involved in the mitogen-activated protein kinase (MAPK) pathway. BRAF …

Advances in targeted therapies for pediatric brain tumors

T Mueller, ASG Stucklin, A Postlmayr, S Metzger… - … Treatment Options in …, 2020 - Springer
Abstract Purpose of Review Over the last years, our understanding of the molecular biology
of pediatric brain tumors has vastly improved. This has led to more narrowly defined …